Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study

doi:10.5306/wjco.v13.i6.529

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3429)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

143

WORD

HTML

1554

Figures (1-4)

154

Tables (1-4)

147

Sum=2052

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

199

Download

483

Sum=682

Publishing Process of This Article

Item

Count

Browse

247

Download

448

Sum=695

Jun 24, 2022 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Oncol. Jun 24, 2022; 13(6): 529-539
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.529

Full Size Figure Download Figure

Figure 4 Association of post-treatment serum carcinoembryonic antigen with bone metastases. CEA: Carcinoembryonic antigen.

Citation: Anoop TM, Joseph P R, Soman S, Chacko S, Mathew M. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study. World J Clin Oncol 2022; 13(6): 529-539
URL: https://www.wjgnet.com/2218-4333/full/v13/i6/529.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i6.529